Lipitor Recall

FDA Issues Recall Of Lipitor Over Glass Particles Found In Packaging

by Staff Blogger | November 27th, 2012

November 27, 2012

The U.S. Food and Drug Administration (FDA) issued a voluntary recall on generic versions of the anti-cholesterol medication, Lipitor. CNN News stated the recall was issued due to concerns of small glass particles being packaged with the medications.

40 lots of atorvastatin calcium, which contain 10, 20, and 40 milligram doses of the medication in 90 and 500 count bottles, were affected. The defective medications could cause patients to suffer from a number of drug injuries including laceration or perforation of organs if ingested.

The recall comes after the drug’s manufacturer, Ranbaxy Pharmaceuticals, Inc., came under scrutiny by the FDA after the agency discovered the company falsified tests and information that was submitted about certain medications. This led to a decision earlier this year to ban the India-based company from exporting products into the United States until it could prove it had complied with safety standards.

Those who are in possession of affected medications should contact the pharmacy where the drugs were received in order to get replacement medications and to turn in defective medications.

The Drug Injury Lawyers with Ferrer, Poirot & Wansbrough understand the costs that can be associated with an injury caused by a defective medication. That’s why it is so important to discuss your legal rights with a qualified attorney immediately if you have been caused harm by a medication prescribed to you by a doctor.